Search – Page 126 – Indianapolis Business Journal

Home » Search

Articles

Novo Nordisk buying 2 DiMarchi-launched drug firms

August 27, 2015

Calibrium LLC and MB2 LLC, both based in Carmel, have agreed to be sold for undisclosed amounts. They were developing diabetes drugs discovered by the research team of Richard DiMarchi, a chemistry professor at Indiana University.

Marathon joins unique, Gannett-created race series

August 27, 2015

The Indianapolis Monumental Marathon is one of seven U.S. marathons that have teamed with Virginia-based media conglomerate Gannett Co. to form a nationwide marathon series.

IPS approves pay raises for teachers, new strategic plan

August 28, 2015

Jubilant Indianapolis Public School Board members on Thursday night hailed an aggressive strategic plan and $12 million in pay raises for teachers as a potential turning point for the city’s schools.

Company news

August 31, 2015

The Indiana University School of Medicine has been selected to lead a five-year, $12 million national research project to develop new treatments for inherited cancers and related developmental disorders. The grant comes from the National Cancer Institute. Dr. Wade Clapp, chairman of the department of pediatrics at the IU medical school will serve as the […]

Experimental osteoporosis drug bests Lilly’s Forteo in study

September 2, 2015

The experimental medicine, called romosozumab, showed better results than Eli Lilly and Co.’s Forteo after 12 months, Amgen and UCB said in a joint statement Wednesday.

JPMorgan Chase settles suit over Christ Church trust accounts

September 3, 2015

The Monument Circle church suffered a setback in May after a judge threw out most of the case against the banking giant but give it a chance to refile most of its claims.

Media lack evidence that LGBT measures bring jobs

September 3, 2015

IBJ’s front-page article flies directly in the face of these business arguments. As quoted, the city of Indianapolis, which already has anti-discrimination protections for LGBT, has seen reductions in both high-tech jobs and highly educated workers.

Funding challenges loom over education-reform groups

September 3, 2015

Education reform groups are struggling to raise money locally, even as Indiana is recognized as one of the friendliest in the nation for school reform ideas.

Dunkin’ Donuts franchisee planning big Indy-area expansion

September 9, 2015

A franchisee of the coffee and doughnut chain that owns all 14 area stores is preparing to open 31 additional locations within the next seven years.

Drug-price increases slow as benefits managers get tough

September 10, 2015

A new analysis shows attempts by drugmakers to raise prices are being wiped out in negotiations with managers of drug insurance benefits like Express Scripts Holding Co. and CVS Health Corp.

MAURER: Let’s build the perfect presidential candidate

September 10, 2015

Absent any great choices, I’m daydreaming about who would get my vote.

Lilly leaps into new frontier of cancer drugs

September 10, 2015

For two years, Eli Lilly and Co. has been building a team of immuno-oncology researchers in New York City and has struck a series of deals with other drug companies.

Lilly shares jump on latest data from diabetes drug

September 17, 2015

A diabetes pill called Jardiance sold by Eli Lilly and Co. cut deaths from heart attacks and strokes in thousands of patients, the first drug to show promise in helping subdue two of the world’s most rampant health epidemics.

Simon proposing major Circle Centre revamp

September 17, 2015

Simon Property Group Inc. is proposing an estimated $20 million in improvements to Circle Centre mall, which spurred a downtown renaissance when it opened 20 years ago this month but now is showing signs of struggle.

Jardiance study lifts Lilly shares to 15-year high

September 18, 2015

Eli Lilly shares soared Thursday after study results showed Jardiance sharply reduced chances of dying in diabetic patients at high risk of heart complications. The study prompted at least one analyst to predict the drug could bring in billions of dollars by the end of the decade.

« Previous 1 … 124 125 126 127 128 … 221 Next »

Search Results

4,413 results for '\"eli lilly\"'

Articles

Novo Nordisk buying 2 DiMarchi-launched drug firms

Marathon joins unique, Gannett-created race series

IPS approves pay raises for teachers, new strategic plan

Company news

Experimental osteoporosis drug bests Lilly’s Forteo in study

JPMorgan Chase settles suit over Christ Church trust accounts

Media lack evidence that LGBT measures bring jobs

Funding challenges loom over education-reform groups

Dunkin’ Donuts franchisee planning big Indy-area expansion

Drug-price increases slow as benefits managers get tough

MAURER: Let’s build the perfect presidential candidate

Lilly leaps into new frontier of cancer drugs

Lilly shares jump on latest data from diabetes drug

Simon proposing major Circle Centre revamp

Jardiance study lifts Lilly shares to 15-year high

PETERSON: 16 Tech is rare opportunity for Indianapolis

Lilly’s heart study sets up showdown with Novo’s Victoza

Transcript: IBJ Commercial Real Estate and Construction Power Breakfast

Analyst: Lilly’s Jardiance diabetes pill could be a $6 billion-a-year blockbuster